ASTech Co., Ltd.
Financials
Valuation Metrics
ASTech Co., Ltd.'s Market Cap is ₩597B. At end of 2025 it was ₩1038B. Ranked #1611 of 2,436 in KR market (top 66%), #950 of 1,649 on KOSDAQ (top 58%), #190 of 294 in Materials (top 65%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 59.68B KRW | KR#1,611/2,436 Sec#190/294 |
| Revenue | 22.94B KRW | KR#2,105/2,436 Sec#279/294 |
| Net Income | -912.1M KRW | KR—/2,436 Sec—/294 |
| Total Assets | 118.77B KRW | KR#1,622/2,436 Sec#226/294 |
| Net Assets | 70.59B KRW | KR#1,641/2,436 Sec#225/294 |
| Employees | 43 | KR#2,086/2,436 Sec#258/294 |
| Value | ||
| P/B | 0.85x | KR#1,340/2,436 Sec#214/294 |
| P/S | 2.60x | KR#1,954/2,436 Sec#276/294 |
| FCF Yield | -46.99% | KR—/2,436 Sec—/294 |
| Profitability | ||
| ROE | -1.29% | KR#1,581/2,436 Sec#210/294 |
| ROA | -0.77% | KR#1,575/2,436 Sec#210/294 |
| Op. Margin | -12.43% | KR#2,036/2,436 Sec#276/294 |
| Revenue Growth | -26.05% | KR#2,127/2,436 Sec#279/294 |
| Earnings Growth | -259.65% | KR#1,538/2,436 Sec#203/294 |
| Financial Health | ||
| Debt Ratio | 168.27% | KR#1,420/2,436 Sec#185/294 |
| Total Debt | 40.70B KRW | KR#1,063/2,436 Sec#172/294 |
| FCF | -28.04B KRW | KR#1,981/2,436 Sec#241/294 |
| Cash | 9.95B KRW | KR#1,676/2,436 Sec#203/294 |
| Current Ratio | 1.58x | KR#1,247/2,436 Sec#136/294 |
| Dividend | ||
| Div. Yield | 5.54% | KR#230/2,436 Sec#46/294 |
| Performance | ||
| 1Y Return | -41.47% | KR#1,872/2,436 Sec#244/294 |
| 1M Return | -5.70% | KR#1,449/2,436 Sec#183/294 |
| From 52W High | -59.56% | KR#1,690/2,436 Sec#237/294 |
| 1Y MDD | -60.48% | KR#1,438/2,436 Sec#220/294 |
| Trading | ||
| Volume | 11,860 shares | KR#2,068/2,436 Sec#241/294 |
| Foreign Own. | 14.41% | KR—/2,436 Sec—/294 |
| Per Share | ||
| EPS | -156 KRW | KR—/2,436 Sec—/294 |
| BPS | 11,006 KRW | KR#886/2,436 Sec#138/294 |
Company Info
AESTEK, established in 2005, specializes in the production of chemical raw materials, particularly ultraviolet blocking agents, and received KOSDAQ listing approval in 2023. The company built its business foundation in 2008 by partnering with Samjin Pharmaceutical for technology transfer and material supply. AESTEK produces sunblock raw materials and pharmaceuticals, growing into a specialized materials, parts, and equipment company through technology development and patent acquisition. The company is headquartered in Seocheon-gun, Chungcheongnam-do.